nisoldipine 17 MG 24 HR Extended Release Tablet

INDICATIONS AND USAGE Nisoldipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Prasco Laboratories

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] off label use` `[4] fatigue` `[5] headache` `[6] dyspnoea` `[7] diarrhoea` `[8] pain` `[9] pyrexia` `[10] vomiting`

11 months ago

ROUND YELLOW SCI 501

HOW SUPPLIED

NISOLDIPINE extended release tablets are supplied as 8.5 mg and 17 mg round film coated tablets and 34 mg elliptic film coated tablets. The different strengths can be identified as follows: Strength Color Markings 8.5 mg Oyster SCI 500 17 mg yellow Cream SCI 501 34 mg Burnt orange SCI 503

NISOLDIPINE Tablets are supplied in bottles of 100: NDC Code Strength 66993-472-02 8.5 mg 66993-473-02 17 mg 66993-475-02 34 mg Protect from light and moisture. Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant containers. Rx only Manufactured for: Prasco Laboratories Mason, OH 45040 USA Rev 10/2021 362168

More pills like ROUND SCI 501

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

nisoldipine 17 MG 24 HR Extended Release Tablet

FDA Reported Adverse Reactions [1] drug ineffective [2] nausea [3] off label use [4] fatigue [5] headache [6] dyspnoea [7] diarrhoea [8] pain [9] pyrexia [10] vomiting

ROUND YELLOW SCI 501

More pills like ROUND SCI 501

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] off label use` `[4] fatigue` `[5] headache` `[6] dyspnoea` `[7] diarrhoea` `[8] pain` `[9] pyrexia` `[10] vomiting`